Thanks for the references @hottod - this recent review by Guan is also quite good (Neuren even gets a mention!), section 3 in particular is a good summary of the mode of action of cGP.
https://www.mdpi.com/1420-3049/28/3/1021
I think the subtlety here is that cGP can indeed up and down regulate IGF-1 activity as part of normal homeostasis, but it is dependent on the molar ratio of cGP/IGF-1 –
“The different effects of cGP on endothelial cell survival/growth are dependent on its concentration relative to that of IGF-1, in which a higher cGP/IGF-1 molar ratio leads to a stimulatory effect, whereas a lower cGP/IGF-1 ratio results in an inhibitory effect.”
This is mediated by competitive binding of cGP and IGF-1 to the IGF binding protein IGFBP-3 as shown in the summary diagram from one of Jon’s slides
Given that a low cGP ratio is required to obtain an inhibitory effect, Guan concludes
“In general, the clinical relevance of cGP is in those conditions associated with IGF-1 deficiency…”
So my interpretation remains that NNZ-2591 is unlikely to be useful in CNS indications where the aim is to reduce IGF-1 activity but, tbh, endocrinology is not really my area so happy to stand corrected!
Finally, I note that although IGF-1 levels are elevated in both MDD and schizophrenia, this is not necessarily seen as a negative but rather a response to the diseases. It is questionable, however, whether NNZ-2591 would provide any significant additional benefit as the disease pathophysiology is quite different to neurodevelopmental disorders.
- Forums
- ASX - By Stock
- NEU
- Psychiatric Indications
Psychiatric Indications, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B |
Open | High | Low | Value | Volume |
$15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6044 | $15.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 1411 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1892 | 15.320 |
3 | 2996 | 15.300 |
1 | 1308 | 15.290 |
1 | 300 | 15.280 |
2 | 1892 | 15.270 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 1411 | 2 |
15.620 | 2616 | 3 |
15.660 | 1892 | 1 |
15.680 | 1892 | 1 |
15.710 | 1892 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online